In a rare day for biotech IPOs, Kythera Biopharmaceuticals ($KYTH) and Intercept Pharmaceuticals ($ICPT) hit the public markets Thursday with prices at the high end ...
Shares of Intercept Pharmaceuticals Inc. (NASDAQ:ICPT) fell nearly 16.5 percent to close at $98.20 on Thursday as the company reported third-quarter revenue of $5.2 million, primarily attributed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results